IntegraMed® Adds Austin Fertility Institute to Its Attain Fertility Centers Network

IntegraMed® Adds Austin Fertility Institute to its Attain Fertility Centers Network
AUSTIN, Texas & PURCHASE, N.Y.—-IntegraMed America, Inc. , the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced it had entered into an agreement with Austin Fertility Institute to begin offering IntegraMed’s Attain® IVF Programs to Austin Fertility Institute’s patients.
Read more on Business Wire via Yahoo! Finance

Pennington Biomedical Research Institute And Compellis Pharmaceuticals Complete Phase I Study Of Novel And Patented …
Compellis Pharmaceuticals, Inc., an early-stage pharmaceutical company developing novel mechanism-based therapeutics for the treatment of obesity, announced today with its collaborator Pennington Biomedical Research Institute at Louisiana State University, that they have successfully completed a human Phase I pilot clinical trial.
Read more on PharmaceuticalOnline